KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Johnson & Johnson (JNJ) EBT (2016 - 2025)

Historic EBT for Johnson & Johnson (JNJ) over the last 17 years, with Q3 2025 value amounting to $7.5 billion.

  • Johnson & Johnson's EBT rose 12447.57% to $7.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $31.5 billion, marking a year-over-year increase of 7872.46%. This contributed to the annual value of $16.7 billion for FY2024, which is 1078.87% up from last year.
  • As of Q3 2025, Johnson & Johnson's EBT stood at $7.5 billion, which was up 12447.57% from $6.5 billion recorded in Q2 2025.
  • Johnson & Johnson's EBT's 5-year high stood at $13.6 billion during Q1 2025, with a 5-year trough of -$1.3 billion in Q2 2023.
  • Over the past 5 years, Johnson & Johnson's median EBT value was $5.2 billion (recorded in 2022), while the average stood at $5.2 billion.
  • Per our database at Business Quant, Johnson & Johnson's EBT crashed by 12473.57% in 2023 and then soared by 38857.81% in 2024.
  • Quarter analysis of 5 years shows Johnson & Johnson's EBT stood at $3.8 billion in 2021, then surged by 34.37% to $5.2 billion in 2022, then fell by 6.69% to $4.8 billion in 2023, then dropped by 19.46% to $3.9 billion in 2024, then soared by 92.77% to $7.5 billion in 2025.
  • Its EBT was $7.5 billion in Q3 2025, compared to $6.5 billion in Q2 2025 and $13.6 billion in Q1 2025.